scholarly article | Q13442814 |
P2093 | author name string | Hanne Thiede | |
Alia A Al-Tayyib | |||
Stephen Koester | |||
Richard D Burt | |||
P2860 | cites work | A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs | Q24629455 |
Self-reported hepatitis C virus antibody status and risk behavior in young injectors | Q27478003 | ||
Trends in the population prevalence of people who inject drugs in US metropolitan areas 1992-2007 | Q28533642 | ||
Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence | Q29616009 | ||
The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
Insurance status and treatment candidacy of hepatitis C patients: analysis of population-based data from the United States | Q33819963 | ||
Temporal trends in highly active antiretroviral therapy initiation among injection drug users in Baltimore, Maryland, 1996-2008 | Q33867166 | ||
Management of acute hepatitis C. | Q34096207 | ||
Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. | Q34294185 | ||
Health and oral health care needs and health care-seeking behavior among homeless injection drug users in San Francisco | Q34420194 | ||
Changes in blood-borne infection risk among injection drug users | Q34772870 | ||
Influence of cannabis use on severity of hepatitis C disease | Q35250832 | ||
Hepatitis B virus infection and vaccination among young injection and non-injection drug users: missed opportunities to prevent infection | Q35612492 | ||
Prevalence, distribution, and correlates of hepatitis C virus infection among homeless adults in Los Angeles | Q36005257 | ||
Management and treatment of injection drug users with hepatitis C virus (HCV) infection and HCV/human immunodeficiency virus coinfection | Q36054688 | ||
Awareness of hepatitis C diagnosis is associated with less alcohol use among persons co-infected with HIV. | Q36102882 | ||
Barriers and missed opportunities to HIV testing among injection drug users in two Mexico--US border cities | Q36376943 | ||
Estimating the prevalence of injection drug users in the U.S. and in large U.S. metropolitan areas from 1992 to 2002. | Q36579571 | ||
Prospective study of hepatitis B vaccination in patients with chronic hepatitis C. | Q36598495 | ||
Global estimates of prevalence of HCV infection among injecting drug users. | Q36940143 | ||
Current approaches to HCV infection in current and former injection drug users | Q37235530 | ||
Integrating health and prevention services in syringe access programs: a strategy to address unmet needs in a high-risk population | Q37391641 | ||
Evolving epidemiology of hepatitis C virus in the United States | Q38020157 | ||
Is the HCV-HIV co-infection prevalence amongst injecting drug users a marker for the level of sexual and injection related HIV transmission? | Q39559399 | ||
Convenience is the key to hepatitis A and B vaccination uptake among young adult injection drug users | Q39784966 | ||
Drug users' participation in a free hepatitis B vaccination program: demographic, behavioral, and social-cognitive determinants | Q40018108 | ||
The future face of coinfection: prevalence and incidence of HIV and hepatitis C virus coinfection among young injection drug users | Q40507515 | ||
Integrated prevention services for HIV infection, viral hepatitis, sexually transmitted diseases, and tuberculosis for persons who use drugs illicitly: summary guidance from CDC and the U.S. Department of Health and Human Services. | Q42287352 | ||
HIV infection and HIV-associated behaviors among injecting drug users - 20 cities, United States, 2009. | Q42638314 | ||
Cannabis use correlates of syringe sharing among injection drug users | Q42662858 | ||
Prevalence of hepatitis C virus infection among injection drug users in the United States, 1994-2004. | Q42978282 | ||
Quality of care in patients with chronic hepatitis C virus infection: a cohort study | Q42999268 | ||
Hepatitis C virus infection: prevalence, predictor variables and prevention opportunities among drug users in Italy | Q43046518 | ||
Daily cannabis use: a novel risk factor of steatosis severity in patients with chronic hepatitis C. | Q43047280 | ||
Hepatitis B vaccination coverage among adults--United States, 2004. | Q43499045 | ||
Health care utilization among young adult injection drug users in Harlem, New York | Q43730966 | ||
Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Centers for Disease Control and Prevention. | Q43784733 | ||
Satisfaction with access to health care among injection drug users, other drug users, and nonusers | Q44007915 | ||
Barriers to enrollment in drug abuse treatment and suggestions for reducing them: opinions of drug injecting street outreach clients and other system stakeholders | Q44844003 | ||
The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007. | Q44979610 | ||
Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study | Q45413375 | ||
Hepatitis and human immunodeficiency virus co-infection among injection drug users in Los Angeles County, California | Q45415523 | ||
Poor validity of self-reported hepatitis B virus infection and vaccination status among young drug users | Q45694402 | ||
Moderate, excessive or heavy alcohol consumption: each is significantly associated with increased mortality in patients with chronic hepatitis C. | Q45731609 | ||
Confronting the emerging epidemic of HCV infection among young injection drug users. | Q51847014 | ||
A randomized trial of a hepatitis care coordination model in methadone maintenance treatment. | Q51867806 | ||
Respondent-Driven Sampling: A New Approach to the Study of Hidden Populations | Q56505053 | ||
Individual and network factors associated with prevalent hepatitis C infection among rural Appalachian injection drug users | Q61098957 | ||
Providing hepatitis B vaccination to injection drug users: referral to health clinics vs on-site vaccination at a syringe exchange program | Q77088496 | ||
Health care need and utilization: a preliminary comparison of injection drug users, other illicit drug users, and nonusers | Q77346077 | ||
P433 | issue | 2 | |
P304 | page(s) | 330-340 | |
P577 | publication date | 2015-02-01 | |
P1433 | published in | Prevention Science | Q15751089 |
P1476 | title | Unmet health care needs and hepatitis C infection among persons who inject drugs in Denver and Seattle, 2009. | |
P478 | volume | 16 |
Search more.